People with diabetes and others taking glucagon-like peptide-1 receptor agonists (GLP-1RAs) should be monitored for nutritional deficiencies and muscle loss, researchers said. "We found that adults ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results